CO2021000763A2 - Estabilidad de la vitamina d en b-hidroxi- b-metilbutirato(hmb) - Google Patents
Estabilidad de la vitamina d en b-hidroxi- b-metilbutirato(hmb)Info
- Publication number
- CO2021000763A2 CO2021000763A2 CONC2021/0000763A CO2021000763A CO2021000763A2 CO 2021000763 A2 CO2021000763 A2 CO 2021000763A2 CO 2021000763 A CO2021000763 A CO 2021000763A CO 2021000763 A2 CO2021000763 A2 CO 2021000763A2
- Authority
- CO
- Colombia
- Prior art keywords
- vitamin
- hmb
- methylbutyrate
- hydroxy
- stability
- Prior art date
Links
- 229940046008 vitamin d Drugs 0.000 title abstract 3
- AXFYFNCPONWUHW-UHFFFAOYSA-N 3-hydroxyisovaleric acid Chemical compound CC(C)(O)CC(O)=O AXFYFNCPONWUHW-UHFFFAOYSA-N 0.000 title 1
- 229930003316 Vitamin D Natural products 0.000 abstract 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 235000019166 vitamin D Nutrition 0.000 abstract 2
- 239000011710 vitamin D Substances 0.000 abstract 2
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract 2
- 230000015556 catabolic process Effects 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862689305P | 2018-06-25 | 2018-06-25 | |
| PCT/US2019/038948 WO2020263229A1 (fr) | 2019-06-25 | 2019-06-25 | STABILITÉ DE LA VITAMINE D DANS DU β-HYDROXY-β-MÉTHYLBUTYRATE (HMB) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2021000763A2 true CO2021000763A2 (es) | 2021-04-08 |
Family
ID=75293630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2021/0000763A CO2021000763A2 (es) | 2018-06-25 | 2021-01-25 | Estabilidad de la vitamina d en b-hidroxi- b-metilbutirato(hmb) |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP3836803A4 (fr) |
| BR (1) | BR112020026621A2 (fr) |
| CO (1) | CO2021000763A2 (fr) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060019933A1 (en) * | 2004-07-22 | 2006-01-26 | David Boardman | Process for preparing stabilized vitamin D |
| WO2012109105A1 (fr) * | 2011-02-07 | 2012-08-16 | Abbott Laboratories | Produits à finalité nutritionnelle comportant du bêta-hydroxy-bêta-méthylbutyrate |
| WO2015137965A1 (fr) * | 2014-03-14 | 2015-09-17 | Metabolic Technologies, Inc. | Liquides et produits alimentaires contenant du bêta-hydroxy-bêta-méthylbutyrate (hmb) sous forme d'acide libre |
-
2019
- 2019-06-25 BR BR112020026621-3A patent/BR112020026621A2/pt unknown
- 2019-06-25 EP EP19935709.6A patent/EP3836803A4/fr active Pending
-
2021
- 2021-01-25 CO CONC2021/0000763A patent/CO2021000763A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3836803A4 (fr) | 2022-07-20 |
| EP3836803A1 (fr) | 2021-06-23 |
| BR112020026621A2 (pt) | 2021-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2019000586A1 (es) | Composiciones de toxinas clostridiales no proteicas. | |
| CR20170356A (es) | Composiciones farmacéuticas para terapia combinada | |
| AR088382A1 (es) | Formulaciones de etanercept estabilizadas con xilitol | |
| AR098168A1 (es) | Formulación estable de insulina glulisina | |
| CL2020002252A1 (es) | Formulación oftálmica. | |
| CL2016002560A1 (es) | Forma de dosificación farmacéutica sólida oral que comprende siponimod, un agente protector de la humedad y opcionalmente un excipiente farmacéutico; procedimiento de preparación. | |
| CR20200550A (es) | Formulaciones de inmunoconjugado anti-cd79b estables | |
| BR112019012099A2 (pt) | composições e métodos de higiene bucal para branqueamento dos dentes | |
| GEP20237486B (en) | Formulations of copanlisib | |
| CO2018007810A2 (es) | Formulación líquida estable de gonadotropina | |
| BR112017004948A2 (pt) | formulação farmacêutica. | |
| BR112018003617A2 (pt) | adesivo não aquoso compreendendo lidocaína e método para administrar referido adesivo | |
| CL2019002516A1 (es) | Composiciones cosméticas para el cuidado de la piel. | |
| CL2021003065A1 (es) | Formulaciones de terlipressina | |
| CL2019002514A1 (es) | Composiciones cosméticas para el cuidado de la piel. | |
| ECSP19073317A (es) | Combinación farmacéutica que comprende ponesimod | |
| BR112018012043A2 (pt) | processo para a redução da transpiração | |
| MY185605A (en) | Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor | |
| CO2023000239A2 (es) | Excipientes reductores de viscosidad y combinaciones de los mismos para formulaciones de proteína altamente concentradas | |
| CO2021000763A2 (es) | Estabilidad de la vitamina d en b-hidroxi- b-metilbutirato(hmb) | |
| CO2019000604A2 (es) | Composición vaginal que comprende una combinación de estrógeno y vitamina d | |
| CO2018010357A2 (es) | Composiciones y métodos para estabilizar alfavirus con formulaciones mejoradas | |
| ECSP20026436A (es) | Métodos de uso y composiciones que contienen dulaglutida | |
| CO2020003134A2 (es) | Moduladores de la expresión de enac | |
| CO2019007261A2 (es) | Combinación de un inhibidor de mcl-1 y un compuesto taxano, usos y composiciones farmacéuticas de ésta |